Expert Interview
A Second View: Gaining insight into the newly approved iLet Bionic Pancreas Insulin Pump for Type 1 Diabetes
Ticker(s): BETA BIONICS, TNDM, PODD, ABT, MDTInstitution: Diabetes and Metabolism Specialists
- Endocrinologist at Diabetes and Metabolism Specialists in San Antonio, Texas
- Diabetes and Metabolism physician who manages over 500 type 1 diabetes patients, 300 of which are on insulin pumps
- Research interest in initiation, titration, and switching of basal insulins
Describe your background and practice setting
Added By: ben_adminHow many patients with type 1 diabetes do you manage?
Added By: ben_adminWhich insulin pumps do your patients currently utilize?
Added By: ben_adminWhat are the most important factors for patients and physicians when considering a new pump?
Added By: ben_adminWhat is your opinion of the newest pump approved from Beta Bionics?
Added By: ben_adminHow many patients do you think you will recommend the iLet Bionic pancreas to in the next 12 months?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
